Medtronic announced a cash tender offer on March 31 for up to $2.75 billion in aggregate purchase price for outstanding debt issued by Medtronic, Inc. and Covidien International Finance S.A., two of the company’s wholly-owned subsidiaries.

Edwards Lifesciences Corp. announced that Steven R. Loranger had been appointed to its board of directors.

By 2022, the global market for lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons, carotid stents, renal stents and other peripheral vascular interventions will increase to $3.4 billion, up from $2.1 billion last year.

A Florida businessman was sentenced to more than 14 years in prison for his role in a healthcare fraud and money laundering scheme, according to a Department of Justice (DOJ) news release.

A microsimulation cardiovascular disease risk prediction model found that a 10 percent subsidy on the price of fruits and vegetables would lead to reductions in cardiovascular disease deaths, non-fatal MI and non-fatal stroke. 

Lawyers for patients suing Johnson & Johnson and Bayer allege that the companies misled editors at The New England Journal of Medicine about the safety of rivaroxaban (Xarelto), the New York Times reports. 

During the third quarter of fiscal year 2016, Medtronic’s revenue increased six percent to $6.394 billion, while its diluted earnings per share decreased one percent to $0.77 per share.

For the fourth quarter of fiscal year 2016, Medtronic will increase its cash dividend by 25 percent to $0.38 per ordinary share, the company announced on Feb. 19.